182 related articles for article (PubMed ID: 37669935)
21. Degradation of AZGP1 suppresses apoptosis and facilitates cholangiocarcinoma tumorigenesis via TRIM25.
Yun H; Jeong HR; Kim DY; You JE; Lee JU; Kang DH; Koh DI; Ryu YS; Bae S; Jin DH
J Cell Mol Med; 2024 Feb; 28(3):e18104. PubMed ID: 38183356
[TBL] [Abstract][Full Text] [Related]
22. Histone acetyltransferase inhibitor C646 reverses epithelial to mesenchymal transition of human peritoneal mesothelial cells via blocking TGF-β1/Smad3 signaling pathway in vitro.
Yang Y; Liu K; Liang Y; Chen Y; Chen Y; Gong Y
Int J Clin Exp Pathol; 2015; 8(3):2746-54. PubMed ID: 26045780
[TBL] [Abstract][Full Text] [Related]
23. Effect and Mechanism of the Lenvatinib@H-MnO
Ning Z; Yang L; Yan X; Wang D; Hua Y; Shi W; Lin J; Meng Z
Curr Pharm Des; 2022; 28(9):743-750. PubMed ID: 35049427
[TBL] [Abstract][Full Text] [Related]
24. COUP-TFII promotes metastasis and epithelial-to-mesenchymal transition through upregulating Snail in human intrahepatic cholangiocarcinoma.
Lang Q; Xiao P; Zhao M; Liang D; Meng Q; Pei T
Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(11):1247-1256. PubMed ID: 33166992
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive multiple molecular profile of epithelial mesenchymal transition in intrahepatic cholangiocarcinoma patients.
Huang XY; Zhang C; Cai JB; Shi GM; Ke AW; Dong ZR; Zhang PF; Fan J; Peng BG; Zhou J
PLoS One; 2014; 9(5):e96860. PubMed ID: 24816558
[TBL] [Abstract][Full Text] [Related]
26. STAT3 aggravates TGF-β1-induced hepatic epithelial-to-mesenchymal transition and migration.
Wang B; Liu T; Wu JC; Luo SZ; Chen R; Lu LG; Xu MY
Biomed Pharmacother; 2018 Feb; 98():214-221. PubMed ID: 29268242
[TBL] [Abstract][Full Text] [Related]
27. LncRNA-CCAT1 Promotes Migration, Invasion, and EMT in Intrahepatic Cholangiocarcinoma Through Suppressing miR-152.
Zhang S; Xiao J; Chai Y; Du YY; Liu Z; Huang K; Zhou X; Zhou W
Dig Dis Sci; 2017 Nov; 62(11):3050-3058. PubMed ID: 28921383
[TBL] [Abstract][Full Text] [Related]
28. Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications.
Zhang C; Liu LX; Dong ZR; Shi GM; Cai JB; Zhang PF; Ke AW; Yu JX; Zhou J; Fan J
Tumour Biol; 2015 Mar; 36(3):1781-9. PubMed ID: 25391422
[TBL] [Abstract][Full Text] [Related]
29. Intrahepatic cholangiocarcinoma escapes from growth inhibitory effect of transforming growth factor-beta1 by overexpression of cyclin D1.
Zen Y; Harada K; Sasaki M; Chen TC; Chen MF; Yeh TS; Jan YY; Huang SF; Nimura Y; Nakanuma Y
Lab Invest; 2005 Apr; 85(4):572-81. PubMed ID: 15696189
[TBL] [Abstract][Full Text] [Related]
30. Qinggan Huoxue Recipe suppresses epithelial-to-mesenchymal transition in alcoholic liver fibrosis through TGF-β1/Smad signaling pathway.
Wu T; Chen JM; Xiao TG; Shu XB; Xu HC; Yang LL; Xing LJ; Zheng PY; Ji G
World J Gastroenterol; 2016 May; 22(19):4695-706. PubMed ID: 27217701
[TBL] [Abstract][Full Text] [Related]
31. Insights into the role of STAT3 in intrahepatic cholangiocarcinoma (Review).
Yang R; Song Y; Shakoor K; Yi W; Peng C; Liu S
Mol Med Rep; 2022 May; 25(5):. PubMed ID: 35302174
[TBL] [Abstract][Full Text] [Related]
32. Linoleic acid pathway disturbance contributing to potential cancerization of intrahepatic bile duct stones into intrahepatic cholangiocarcinoma.
Li J; Lu J; Lv S; Sun S; Liu C; Xu F; Sun H; Yang J; Wang X; Zhong X; Lu J
BMC Gastroenterol; 2022 May; 22(1):269. PubMed ID: 35637430
[TBL] [Abstract][Full Text] [Related]
33. A Novel Trojan Horse Nanotherapy Strategy Targeting the cPKM-STMN1/TGFB1 Axis for Effective Treatment of Intrahepatic Cholangiocarcinoma.
Chen ZW; Kang FP; Xie CK; Liao CY; Li G; Wu YD; Lin HY; Zhu SC; Hu JF; Lin CF; Huang Y; Tian YF; Huang L; Wang ZW; Chen S
Adv Sci (Weinh); 2023 Nov; 10(32):e2303814. PubMed ID: 37789644
[TBL] [Abstract][Full Text] [Related]
34. Conversion therapy for advanced intrahepatic cholangiocarcinoma with lenvatinib and pembrolizumab combined with gemcitabine plus cisplatin: A case report and literature review.
Zhang W; Luo C; Zhang ZY; Zhang BX; Chen XP
Front Immunol; 2022; 13():1079342. PubMed ID: 36700218
[TBL] [Abstract][Full Text] [Related]
35. Kaempferol Suppresses Transforming Growth Factor-β1-Induced Epithelial-to-Mesenchymal Transition and Migration of A549 Lung Cancer Cells by Inhibiting Akt1-Mediated Phosphorylation of Smad3 at Threonine-179.
Jo E; Park SJ; Choi YS; Jeon WK; Kim BC
Neoplasia; 2015 Jul; 17(7):525-37. PubMed ID: 26297431
[TBL] [Abstract][Full Text] [Related]
36. M2-polarized tumor-associated macrophages promote epithelial-mesenchymal transition via activation of the AKT3/PRAS40 signaling pathway in intrahepatic cholangiocarcinoma.
Sun D; Luo T; Dong P; Zhang N; Chen J; Zhang S; Dong L; Janssen HLA; Zhang S
J Cell Biochem; 2020 Apr; 121(4):2828-2838. PubMed ID: 31692069
[TBL] [Abstract][Full Text] [Related]
37. Crenigacestat blocking notch pathway reduces liver fibrosis in the surrounding ecosystem of intrahepatic CCA viaTGF-β inhibition.
Mancarella S; Gigante I; Serino G; Pizzuto E; Dituri F; Valentini MF; Wang J; Chen X; Armentano R; Calvisi DF; Giannelli G
J Exp Clin Cancer Res; 2022 Nov; 41(1):331. PubMed ID: 36443822
[TBL] [Abstract][Full Text] [Related]
38. β4 and β6 Integrin Expression Is Associated with the Subclassification and Clinicopathological Features of Intrahepatic Cholangiocarcinoma.
Soejima Y; Takeuchi M; Akashi T; Sawabe M; Fukusato T
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29584696
[TBL] [Abstract][Full Text] [Related]
39. The role of Tripartite motif containing 59 (TRIM59) in the proliferation and prognosis of intrahepatic cholangiocarcinoma.
Zhang JN; Ding DY; Yang SY; Tao QF; Yang Y; Zhou WP
Pathol Res Pract; 2022 Aug; 236():153989. PubMed ID: 35753134
[TBL] [Abstract][Full Text] [Related]
40. MiR-203a-3p regulates TGF-β1-induced epithelial-mesenchymal transition (EMT) in asthma by regulating Smad3 pathway through SIX1.
Fan Q; Jian Y
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32065213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]